Sodium pseudomonate was shown to be a powerful competitive inhibitor of Escherichia coli B isoleucyl-tRNA synthetase (Ile-tRNA synthetase). The antibiotic competitively inhibits (K1 6nM; cf. Km 6.3jpM), with respect to isoleucine, the formation of the enzyme * Ile -AMP complex as measured by the pyrophosphate-exchange reaction, and has no effect on the transfer of [l4Clisoleucine from the enzyme [ IChile AMP complex to tRNAIe.. The inhibitory constant for the pyrophosphate-exchange reaction was of the same order as that determined for the inhibition of the overall aminoacylation reaction (K, 2.5nM; cf. Km 11.lpM). Sodium [9'-3Hlpseudomonate forms a stable complex with Ile-tRNA synthetase. Gel-filtration and gel-electrophoresis studies showed that the antibiotic is only fully released from the complex by SM-urea treatment or boiling in 0.1% sodium dodecyl sulphate. The molar binding ratio of sodium [9'-3Hlpseudomonate to Ile-tRNA synthetase was found to be 0.85 :1 by equilibrium dialysis. Aminoacylation of yeast tRNAI"e by rat liver Ile-tRNA synthetase was also competitively inhibited with respect to isoleucine, K, 20M (cf. Km 5.4gM). The Km values for the rat liver and E. coli B enzymes were of the same order, but the K, for the rat liver enzyme was 8000 times the K, for the E. coli B enzyme. This presumably explains the low toxicity of the antibiotic in mammals.
We have previously shown (Hughes & Mellows, 1978b) that the primary target of the recently discovered antibiotic pseudomonic acid A (hereafter referred to as pseudomonic acid) in Escherichia coli MRE 600 is Ile-tRNA synthetase. In exponentially growing E. coli MRE 600 cells treated with the antibiotic at its minimum inhibitory concentration (25,ug/ml), only 60% of the tRNA'ie was found to be charged with isoleucine, whereas in untreated cells the tRNAIIe remained fully charged. By using a 150000g supernatant from E. coli MRE 600 cells as a source of aminoacyl-tRNA synthetases, it was also shown that 0.2 mM-sodium pseudomonate inhibited the overall aminoacylation of tRNAIie by 90%. With the exception of the aminoacylation of tRNAPhC, which was inhibited by 10% at the same antibiotic concentration, the antibiotic had no effect on the aminoacylation of tRNAGIY, tRNALcu, tRNAVal, tRNAHIS, tRNATYr and tRNAT I. We have since shown (G. Mellows, Abbreviation used: Ile-tRNA synthetase, isoleucyltRNA synthetase (EC 6.1.1.5) S. Soughton & K. Taylor, unpublished work) that 0.2mM-sodium pseudomonate also has no effect on the activation of the acidic amino acids aspartic acid and glutamic acid with the same enzyme preparation. However, the same concentration of the antibiotic produced a 70% enhancement in the rate of aminoacylation of tRNALYS, although the molecular basis for this is unknown. We also demonstrated that sodium pseudomonate is a powerful inhibitor of electrophoretically pure E. coli B Ile-tRNA synthetase.
In the present paper we describe the steady-state inhibitory kinetics and binding studies of sodium pseudomonate with pure E. coli B Ile-tRNA synthetase. The inhibitory kinetics of rat liver Ile-tRNA synthetase in relation to the low toxicity of the antibiotic in mammals are also discussed. Radioactivity counting This was generally carried out in plastic inserts (5 ml) by using a Beckman LS200B liquid-scintillation counter. Radioactive glass-fibre discs were counted for radioactivity in scintillant A, which contained butyl-PBD [5-(biphenyl-4-yl)-2-(4-t-butylphenyl)-l-oxa-3,4-diazolel (6 g) and naphthalene (SOg) made up to 1 litre with toluene. Aqueous samples were counted for radioactivity in scintillant B, which contained methoxyethanol (5 ml) and scintillant A (10ml).
Materials and methods

Sodium
Glass-fibre discs containing 32P absorbed on Norit A were glued to planchets and counted for radioactivity in a Nuclear-Chicago gas-flow counter.
Synthesis ofsodium [9'-3H]pseudomonate
The synthetic route to sodium [9'-3H]pseudomonate is shown in Scheme 1.
(i) Preparation of nonan-9-aloic acid. To oleic acid (1.6g) was added a solution of KOH (0.8g) in water (32 ml) with stirring. When the mixture was homogeneous a further portion of KOH (0.8 g) was added and ice (32 g) added, lowering the temperature to 0-50C. Finely ground KMnO4 (1.6 g) was added with vigorous stirring and allowed to react for 1min. The mixture was decolourized with SO2, followed by acidification with concentrated HCI. The white precipitate was removed by centrifugation at 5000g for lOmin and crystallized from benzene/ethanol (1:2, v/v) to give erythro-9,10-dihydroxystearic acid (1.4 g).
A solution of the diol (1.4g) in ethanol (140ml) and water (10ml) was treated at room temperature Overall aminoacylation of Ile-tRNA synthetase. The rate of isoleucylAtRNAIIe formation was followed by the procedure of Durekovic et al. (1973) . The reaction mixture (100pl) contained 100mM-Tris/HCl, pH 7.5, 2 mM-dithiothreitol, 12A260 units of bulk tRNA, lOmM-MgCl2, 10mM-KCl, 1 mM-ATP, 0.01-0.1 mM-[14C]isoleucine, 0-50nM-sodium pseudomonate and 0.1 pg of Ile-tRNA synthetase. The reaction mixture was pre-equilibrated at 370C and the reaction timed from the addition of the enzyme. After incubation at 370C for 3 min, the reaction was quenched by the addition of 5% (v/v) trichloroacetic acid (2 ml) and the mixture kept at 0-40C for 30min. The precipitate was collected on a Whatman GF/C glass-fibre filter, washed successively with 5% trichloroacetic acid (2 x lOml) and ethanol (2 x lOml), dried and counted for radioactivity in scintillant A.
[32P]Pyrophosphate exchange into A TP. The reaction mixture (1 ml) contained lOmM-Tris/HCl, pH 7.5, SmM-MgCl2, lOmM-KF, 2mM-ATP, 10mM-dithiothreitol, 2-20uM-isoleucine, 0-50nM-sodium pseudomonate, 250pg of Ile-tRNA synthetase and Na432P207 (2,umol; 104-10 c.p.m./pmol of pyrophosphate). The reaction mixture was pre-equili- Vol. 191 brated at 370C and the reaction timed from the addition of the enzyme. After incubation at 370C for 5min, the reaction was quenched with 7% (w/v) HCl04 (0.5 ml) and an aq. 10% (v/v) suspension of Norit A (0.2ml) added. After 20min at room temperature, the Norit A was collected on a Whatman GF/C glass-fibre filter. The filter was thoroughly washed with distilled water, glued to a planchet and counted for radioactivity in a gas-flow counter.
Isolation of Ile-tRNA synthetase.
[14C]Ile_.AMP complex. fle-tRNA synthetase (500,g) was added to a reaction mixture containing 2 mM-sodium ATP, 5mM-MgCl2, 0.2 unit of inorganic pyrophosphatase (l,ug), 0.1 mM-EDTA, lOmM-dithiothreitol, 20mM-[I4C]isoleucine (0.4,Ci) and 20mM-phosphate buffer, pH 7.5. After 2min, Blue Dextran was added. The mixture was eluted through a Sephadex G-50 (coarse grade) column (0.5cm x 28cm) with 0.1 Msodium citrate buffer (pH 6.1) containing 0.05 M-KCI and 5 mM-dithiothreitol (the column was pre-equilibrated with the same buffer before use); 160 (25,u1) of each was counted for radioactivity in scintillant B. Portions (50,ul) of alternate samples were qualitatively tested for protein by using the procedure of McKnight (1977) .
The sodium [9'-3H]pseudomonate * Ile-tRNA synthetase complex was also treated with 0.1% sodium dodecyl sulphate at room temperature and 1000C before gel filtration. In a separate experiment the Sephadex G-50 column was pre-equilibrated with the same buffer additionally containing unlabelled sodium pseudomonate at the same concentration as that used in the incubation mixture. Gel filtration was then conducted with the same sodium pseudomonate/buffer mixture.
The results are collected in Fig. 5 
Results
Previous work has shown that sodium pseudomonate causes arrest of protein synthesis in prokaryotic organisms both in vivo and in vitro by specifically interfering with the function of isoleucyl-tRNA synthetase (Hughes & Mellows, 1978a,b (Rainey et aL, 1977) . t Km (literature) 4-6juM (Cole & Schimmel, 1970; Fersht & Kaethner, 1976; Helene et al., 1971; Loftfield & Eigner, 1965; Rainey et al., 1977) . The results are depicted in Fig. 4 . As was demonstrated for the E. coli B enzyme, sodium pseudomonate, in the concentration range 0-200pm, is a competitive inhibitor of the rat liver Ile-tRNA synthetase, with respect to isoleucine. The inhibitory constant (K, , 20, UM) , is four times the Michaelis constant (Ki, 5.4, UM) , and is 8000 times the K, for the E. coli B enzyme. Gel filtration. When Ile-tRNA synthetase and an excess of sodium [9'-3Hlpseudomonate were incubated at pH 7.2 in the presence of dithiothreitol, followed by gel filtration on Sephadex G-50 (fine grade) pre-equilibrated and eluted with the same buffer containing the same concentration of nonradioactive sodium pseudomonate, the molar binding ratio of sodium [9'-3Hlpseudomonate to IletRNA synthetase was found to be 0.73 :1 (Fig. Sa) . The same result was obtained when non-radioactive sodium pseudomonate was excluded from the eluting buffer, confirming that the sodium [9'-3Hlpseudo-monate .Ile-tRNA synethatse complex is extremely stable and that no equilibrium of the labelled antibiotic in the complex with unlabelled antibiotic in the eluent buffer took place on gel filtration in the former experiment. Inclusion of 50,pM-ATP in the reaction mixture did not change the binding ratio. Addition of 0.1% sodium dodecyl sulphate at 240C to the reaction mixture before gel filtration resulted in partial breakdown of the antibiotic . Ile-tRNA synthetase complex, lowering the molar binding ratio to 0.5 :1 (Fig. Sb) . Boiling in 0.1% sodium dodecyl sulphate resulted in the complete fragmentation of the antibiotic Ile-tRNA synthetase complex (Fig.  5c ). When sodium [9'-3Hlpseudomonate was incubated with bovine serum albumin in lieu of Ile-tRNA synthetase at the same molar concentration, no binding was observed on gel filtration. This implied that the binding of sodium pseudomonate to IletRNA synthetase is specific and not random. Table 3 . Effect ofsodium pseudomonate on aminoacylation of tRNA species in vitro with a rat liver aminoacyltRNA synthetase preparation By using a dialysed 200000g supernatant from rat liver as a source of aminoacyl-tRNA synthetases, the aminoacylation of different tRNA species with the corresponding U-14C-labelled amino acid was determined in the presence and absence of 0.2 mmsodium pseudomonate (lOO,ug/ml) as described in the Materials and methods section. The degree of inhibition of aminoacylation was calculated from the incorporation of 14C into trichloroacetic acidprecipitable material in the presence and absence of sodium pseudomonate. Effect of sodium pseudomonate on other rat liver aminoacyl-tRNA synthetases In addition to producing a marked inhibitory effect on E. coli Ile-tRNA synthetase, sodium pseudomonate also weakly inhibits the function of phenylalanyl-tRNA synthetase from the same organism (Hughes & Mellows, 1978b) .
Interestingly, 0.2mM-sodium pseudomonate also weakly inhibits rat liver phenylalanyl-tRNA synthetase (Table 3) , whereas the antibiotic was without effect on leucine and valine activation.
Discussion
We have previously shown that sodium pseudomonate is a powerful inhibitor of Ile-tRNA synthetase from E. coli MRE 600. To date, Ile-tRNA synthetase has been purified to homogeneity from three E. coli strains, K12, MRE 600 and B. The enzyme from all three sources is a single polypeptide chain (Fayat et al., 1974; Durekovic et al., 1973; Arndt & Berg, 1970) . The reported molecular weight of the E. coli B and K 12 enzymes is 110000 (Baldwin & Berg, 1966; Fayat et al., 1974) , whereas the E. coli 600 enzyme has a reported molecular weight of 102000 (Durekovic et al., 1973) . The three distinct enzymes appear to be structurally different, as manifested by minor differences in amino acid composition (Table 4 ) and the demonstration of different N-terminal sequences for the E. coli B and MRE 600 enzymes (Durekovic et al., 1973) . The reaction catalysed by E. coli K12 Ile-tRNA synthetase has been conclusively shown to occur in two discrete stages through the intermediacy of an enzyme . isoleucyladenylate complex (Fersht & Kaethner, 1976 (Fersht & Kaethner, 1976) suggests that the rate-determining step for the E. coli K 12 enzyme is the transfer of the isoleucyl moiety from the enzyme . Ile -AMP complex to tRNAIIe. Yarus & Berg (1969) and Eldred & Schimmel (1972) have presented evidence supporting the dissociation of the aminoacylated tRNA from the E. coli B enzyme as the rate-determining step, but the opposite conclusion was reached in a more recent study (L6vgren et al., 1976) . All three enzymes have a requirement for an active thiol group, and the sequence surrounding the cysteine residue in the E. coli MRE 600 enzyme has been reported (Kula, Interaction of pseudomonic acid with isoleucvl tRNA synthetase (Baldwin & Berg, 1966) (Fersht & Kaethner, 1976 (Norris & Berg, 1964; Yarus & Berg, 1967 We and others (Hughes & Mellows, 98a; Sutherland et al., 1976) have previously noted that sodium pseudomonate is relatively specific for prokaryotic organisms and has a relatively low potency towards eukaryotic organisms. This prompted us to examine the effect of the antibiotic on the mammalian enzyme. The steady-state inhibitory kinetics of the rat liver Ile-tRNA synthetase was also found to be competitive with respect to isoleucine. The inhibitory constant (K,, 20pm We have previously suggested (Hughes & Mellows, 1978b,c) that the terminus of the side chain containing the epoxide group in the antibiotic, which has the same carbon skeleton as L-isoleucine, competes for the single isoleucine-binding site (Norris & Berg, 1964) on the enzyme (Fig. 6) Hughes & Mellows, 1978b.) alternative possibility that the antibiotic binds at a site close to the isoleucine-binding site, thereby preventing isoleucine entry to the site. It seems unlikely to us that this would be the case, since it is difficult to see how an excess of isoleucine would counteract the presumed highly specific binding of sodium pseudomonate, unless isoleucine could also bind at the second site and its binding constant for this site is comparable with that of the antibiotic. To date, there is no evidence for a second isoleucine-binding site which is capable of binding isoleucine to this extent.
The results of two previous investigations in which the binding of structurally related compounds to isoleucine, ATP and pyrophosphate to Ile-tRNA synthetase was studied (Holler et al., 1973; Flossdorf et al., 1976) have provided strong evidence for the presence of two hydrophobic sites, respectively accommodating the methyl and ethyl groups of isoleucine in the isoleucine-binding domain of the enzyme. Holler et al. (1973) further proposed that entrance to the isoleucine-binding domain is an ion-pair 'gate', and that prebinding of ATP at a site in close proximity to the isoleucine-binding domain assists the opening of the ion-pair interaction of the a -ammonium and carboxylate groups of isoleucine with the respective negative and positive components of the ion-pair and would serve to stabilize the Ile-tRNA synthetase * ATP . Ile complex. It was also suggested (Holler et al., 1973) that opening of the ion-pair gate could initiate the conformation change that was observed to follow the binding of isoleucine to the enzyme (Yarus & Berg, 1969; Holler et al., 1971; Holler & Calvin, 1972) .
In the light of these observations it was decided to see whether ATP prebinding had any effect on the extent of sodium pseudomonate binding. Pretreatment of Ile-tRNA synthetase with lOmM-ATP and lOmM-MgCl2 had no effect on the degree of binding of the antibiotic. Given that sodium pseudomonate competes for the isoleucine-binding site of the enzyme, as the above evidence clearly suggests, and that the epoxide side-chain terminus of the molecule occupies the two hydrophobic domains, then the 'ionpair gate' hypothesis of Holler et al. (1973) must be questioned. It is not, however, beyond the bounds of possibility that, if the proposed ion-pair interaction in native Ile-tRNA synthetase is weak, that the many functionalities in the rest of the antibiotic molecule may be suitably juxtaposed to associate with suitable groups on the enzyme backbone through non-covalent interactions of sufficient total strength to force the epoxide side-chain terminus into the isoleucine-binding domain.
The affinity of the E. coli B enzyme for sodium pseudomonate was further emphasized by the results of Sephadex G-50 gel-filtration studies. The sodium pseudomonate * Ile-tRNA synthetase complex is stable to gel filtration and can be readily isolated.
Treatment of the complex with 0.1% sodium dodecyl sulphate at 24°C results in only partial release of the antibiotic from the complex. Severe denaturing conditions, such as boiling the complex in 0.1% sodium dodecyl sulphate or treatment with 5 M-urea, are necessary to release the antibiotic fully from the complex, presumably through complete unfolding of the protein chain. It was rather surprising that the results of the above experiments and the kinetic studies have shown that the epoxide moiety of the antibiotic is not involved in covalent-bond formation with the enzyme, particularly since it is known that there is an active and essential cysteine thiol residue at or close to the active site(s) (laccarino & Berg, 1969) .
